Skip to main content
. Author manuscript; available in PMC: 2020 Jul 28.
Published in final edited form as: Abdom Radiol (NY). 2018 Feb;43(2):445–456. doi: 10.1007/s00261-017-1338-6

Fig. 2.

Fig. 2.

A 73-year-old woman with unresectable adenocarcinoma of the neck of the pancreas with encasement of celiac axis and portal vein/SMV confluence, treated with gemcitabine, taxotere, and xeloda. Tumor diameter decreased to 89% of the baseline, tumor volume 53%, and CA19–9 10%. A Baseline arterial and B venous phase CT. C Post-chemotherapy arterial and D venous phase CT. Tumor iodine uptake and normalized tumor iodine uptake were A 1.6 mg/mL and 8%, B 2.7 mg/mL and 50%, C 1.0 mg/mL and 7%, and D 1.0 mg/mL and 29%.